BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Duvnjak M, Baršić N, Tomašić V, Lerotić I. Genetic polymorphisms in non-alcoholic fatty liver disease: Clues to pathogenesis and disease progression. World J Gastroenterol 2009; 15(48): 6023-6027 [PMID: 20027673 DOI: 10.3748/wjg.15.6023]
URL: https://www.wjgnet.com/1007-9327/full/v15/i48/6023.htm
Number Citing Articles
1
Lei Lei, Chao Zhou, Xue Yang, Liangping Li. Down‐regulation of microRNA‐375 regulates adipokines and inhibits inflammatory cytokines by targeting AdipoR2 in non‐alcoholic fatty liver diseaseClinical and Experimental Pharmacology and Physiology 2018; 45(8): 819 doi: 10.1111/1440-1681.12940
2
Weaam Gouda, Esmat Ashour, Yehia Shaker, Wafaa Ezzat. MTP genetic variants associated with non-alcoholic fatty liver in metabolic syndrome patientsGenes & Diseases 2017; 4(4): 222 doi: 10.1016/j.gendis.2017.09.002
3
Anna Alisi, Stefano Cianfarani, Melania Manco, Carlo Agostoni, Valerio Nobili. Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: Pathogenetic role of genetic background and intrauterine environmentAnnals of Medicine 2012; 44(1): 29 doi: 10.3109/07853890.2010.547869
4
Gabriella Pár, Gábor Horváth, Alajos Pár. Non-alcoholic fatty liver disease and steatohepatitisOrvosi Hetilap 2013; 154(29): 1124 doi: 10.1556/OH.2013.29626
5
Michelle Bloyd, Nikolaos Settas, Fabio Rueda Faucz, Ninet Sinaii, Kerstin Bathon, James Iben, Steven Coon, Sonia Caprio, Constantine A Stratakis, Edra London. The PRKAR1B p.R115K Variant is Associated with Lipoprotein Profile in African American Youth with Metabolic ChallengesJournal of the Endocrine Society 2021; 5(8) doi: 10.1210/jendso/bvab071
6
Fajar Dwi Astarini, Neneng Ratnasari, Widya Wasityastuti. Update on Non-Alcoholic Fatty Liver Disease-Associated Single Nucleotide Polymorphisms and Their Involvement in Liver Steatosis, Inflammation, and Fibrosis: A Narrative ReviewIranian Biomedical Journal 2022; 26(4): 252 doi: 10.52547/ibj.3647
7
María Guadalupe Sánchez-Parada, Bertha Adriana Alvarez-Rodríguez, Belinda Claudia Gómez-Meda, Rogelio Troyo-Sanromán, Laura Verónica Sánchez-Orozco, Ana Lourdes Zamora-Perez, Martha Silvia Lucano Landeros, Juan Armendáriz-Borunda. Association of Genetic Polymorphisms with Histological Grading of Necroinflammation, Staging of Fibrosis, and Liver Function in Mexicans with Chronic Hepatitis C Virus InfectionJournal of Investigative Medicine 2013; 61(7): 1088 doi: 10.2310/JIM.0b013e3182a32e24
8
Fernanda Domenici, Helio Vannucchi. Role of Oxidative Stress in Chronic Diseases2014; : 260 doi: 10.1201/b16653-16
9
Luc Tappy, Kim-Anne Lê. Does fructose consumption contribute to non-alcoholic fatty liver disease?Clinics and Research in Hepatology and Gastroenterology 2012; 36(6): 554 doi: 10.1016/j.clinre.2012.06.005
10
Wei Zheng, Lu Wang, Xiao Su, Xiao-Fang Hu. MTP −493G>T Polymorphism and Susceptibility to Nonalcoholic Fatty Liver Disease: A Meta-AnalysisDNA and Cell Biology 2014; 33(6): 361 doi: 10.1089/dna.2013.2238
11
Anna Michelotti, Marco de Scordilli, Lorenza Palmero, Michela Guardascione, Mario Masala, Rossana Roncato, Luisa Foltran, Elena Ongaro, Fabio Puglisi. NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic SyndromeCells 2021; 10(8): 2034 doi: 10.3390/cells10082034
12
Yuya Seko, Kanji Yamaguchi, Yoshito Itoh. The genetic backgrounds in nonalcoholic fatty liver diseaseClinical Journal of Gastroenterology 2018; 11(2): 97 doi: 10.1007/s12328-018-0841-9
13
Faisal Alsaif, Waleed Al-hamoudi, Maram Alotaiby, Amani Alsadoon, Mohammed Almayouf, Hadeel Almadany, Jawahir Abuhaimed, Noman Ghufran, Ahmed Merajuddin, Imran Ali Khan. Molecular Screening via Sanger Sequencing of the Genetic Variants in Non-Alcoholic Fatty Liver Disease Subjects in the Saudi Population: A Hospital-Based StudyMetabolites 2022; 12(12): 1240 doi: 10.3390/metabo12121240
14
Agnieszka Kempinska-Podhorodecka, Ewa Wunsch, Piotr Milkiewicz, Ewa Stachowska, Malgorzata Milkiewicz. The Association between SOCS1−1656G>A Polymorphism, Insulin Resistance and Obesity in Nonalcoholic Fatty Liver Disease (NAFLD) PatientsJournal of Clinical Medicine 2019; 8(11): 1912 doi: 10.3390/jcm8111912
15
Bai‐Fang Wang, Ying Wang, Ran Ao, Jing Tong, Bing‐Yuan Wang. AdipoQ T45 G and G276 T Polymorphisms and Susceptibility to Nonalcoholic Fatty Liver Disease Among Asian Populations: A Meta‐Analysis and Meta‐RegressionJournal of Clinical Laboratory Analysis 2016; 30(1): 47 doi: 10.1002/jcla.21814
16
Vincent Zimmer, Frank Lammert. Genetics and epigenetics in the fibrogenic evolution of chronic liver diseasesBest Practice & Research Clinical Gastroenterology 2011; 25(2): 269 doi: 10.1016/j.bpg.2011.02.007
17
Vettickattuparambil George Giby, Thekkuttuparambil Ananthanarayanan Ajith. Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver diseaseWorld Journal of Hepatology 2014; 6(8): 570-579 doi: 10.4254/wjh.v6.i8.570
18
Rohini Mehta, Aybike Birerdinc, Zobair M. Younossi. Host Genetic Variants in Obesity-Related Nonalcoholic Fatty Liver DiseaseClinics in Liver Disease 2014; 18(1): 249 doi: 10.1016/j.cld.2013.09.017
19
R.B. Prussick, L. Miele. Nonalcoholic fatty liver disease in patients with psoriasis: a consequence of systemic inflammatory burden?British Journal of Dermatology 2018; 179(1): 16 doi: 10.1111/bjd.16239
20
Karina Banasik, Johanne M. Justesen, Malene Hornbak, Nikolaj T. Krarup, Anette P. Gjesing, Camilla H. Sandholt, Thomas S. Jensen, Niels Grarup, Åsa Andersson, Torben Jørgensen, Daniel R. Witte, Annelli Sandbæk, Torsten Lauritzen, Bernard Thorens, Søren Brunak, Thorkild I. A. Sørensen, Oluf Pedersen, Torben Hansen, Ying Xu. Bioinformatics-Driven Identification and Examination of Candidate Genes for Non-Alcoholic Fatty Liver DiseasePLoS ONE 2011; 6(1): e16542 doi: 10.1371/journal.pone.0016542
21
Menha Swellam, Nadia M. Hamdy. Association of nonalcoholic fatty liver disease with a single nucleotide polymorphism on the gene encoding leptin receptorIUBMB Life 2012; 64(2): 180 doi: 10.1002/iub.597
22
Simona Alexandra Iacob, Diana Gabriela Iacob. Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis BreakdownFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.814209
23
Daniel Costache, Horia Blejan, Damian Cojocaru, Georgiana Ioniță, Marcela Poenaru, Maria Constantin, Andrei Costache, Constantin Căruntu, Daniel Balaban, Raluca Costache. Intersecting Pathways: Nonalcoholic Fatty Liver Disease and Psoriasis Duet—A Comprehensive ReviewInternational Journal of Molecular Sciences 2024; 25(5): 2660 doi: 10.3390/ijms25052660